[india-drug] clavulanic acid (ir)ratios

[E-drug <e-drug@usa.healthnet.org>]

(Copied from Edrug. Thanks???..SS)


E-DRUG: clavulanic acid (ir)ratios
---------------------------
[we continue a critical review of the essential drugs market. WB]

dear E-druggers,

Clavulanic acid is used as a beta-lactamase inhibitor in fixed dose
combinations with (inter alia) amoxicillin. It has hardly any
antibacterial activity itself, but it can extend the clinical use of
amoxicillin against beta-lactamase producing bacteriae.
Normally, 250 or 500mg amoxicillin is combined with 125mg clavulanic
acid (a 2:1 or 4:1 ratio). The maximum recommended daily dose of
clavulanic acid is 500mg.

The  500+125mg tablet (4:1 ratio) is the one in the current WHO EDL as
a
reserve antibiotic.

Sometimes (e.g., chronic otitis media) there are valid indications to
increase the amoxicillin dose. This should be done by adding plain
amoxicillin, as the maximum dose of clavulanic acid is already provided
in the basic combination product.

Taking 2 tablets of 250+125 is NOT the same as one 500+125 tablet! It
provides the double dose of clavulanic acid, which has been linked to
increased risks of cholestatic hepatotoxicity.

The original manufacturer obviously prefers to sell a (more expensive)
combination product (rather than selling more plain amoxicillin, of
which there are many generic competitors!), and is therefore also
marketing fixed dose combinations with higher ratios. For example, it
markets also chewable tablets of 400+57mg, a 7:1 ratio. However, all
2:1, 4:1 and 7:1 products run under the same brandname Augmentin!

There are also 125+32.25 (4:1), 250+62.5 (4:1), 200+28.5 (7:1) and
400+57 (7:1) suspensions available (all per 5 mL, under the same
brandname Augmentin). In some countries, there is even a 
600+42.9mg/5mL suspension (14:1 ratio, brandname Augmentin ES-600).

In some countries (where there was no patent, or the Augmentin patent
expired) generics are available with 250+62.5 mg...

Are you as confused as I am?

If the amoxicillin-clavulanic acid ratios vary 7-fold from 2:1 to 14:1,
it sounds logical to do away with a fixed dose combination, and to
market clavulanic acid separately from amoxicillin. "Loose" clavulanic
acid is however not available from the original manufacturer (not
profitable?).

So why don't we develop generic clavulanic acid 125mg tablets, and do
away with the fixed dose confusion?

Would this not allow simpler prescribing/dosing, and also prevent the
overdosing of clavulanic acid?

However, as clavulanic acid has no intrinsic antibacterial activity,
could it be registered as a medicine?

Your comments are welcome!

Wilbert Bannenberg

---------
Dr Wilbert Bannenberg, E-drug moderator
Box 456, Irene 0062, South Africa
Mobile +27-82-5756249
Tel +27-12-6671752
Fax +27-12-6671762
Email: WilbertBannenberg@compuserve.com





________________________________________________________________________
Missed your favourite TV serial last night? Try the new, Yahoo! TV.
       visit http://in.tv.yahoo.com
The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@usa.healthnet.org